Literature DB >> 7791493

[Follow-up of plasma endothelin and serum interleukin 2 receptor level after liver transplantation].

T Rudy1, E Fritschka, J Erhard, F W Eigler.   

Abstract

In a prospective study levels of interleukin-2 receptors (Il-2-R) in serum and of endothelin (ET) in plasma were sequentially determined in 97 patients (39 women, 58 men) before and after liver transplantation (Ltx). The aim of the study was no evaluate the correlation and the time course of these two parameters after Ltx. The postoperative levels of Il-2-R and ET were higher in transplant recipients with no postoperative complications than in patients who had undergone operations to the liver. Patients suffering from acute rejection episodes after transplantation had more markedly increased Il-2-R and ET levels than those with an uneventful course, and this persisted for 3 months. A significant rise of Il-2-R concentrations 3-6 days before a biopsy confirmed rejection proved to have a sensitivity of 68% and a specificity of 68% respectively. A corresponding ET increase preceded rejection episodes confirmed by biopsy with a sensitivity of 62% and a specificity of 67%, respectively. These laboratory data can be obtained daily: they cannot undermine the "gold standard" of liver biopsy, but they are extremely beneficial in determining the timing and indication for the liver biopsy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791493     DOI: 10.1007/bf00207728

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  15 in total

1.  Peri and postoperative plasma kinetics of big endothelin and endothelin 1/2 after liver transplantation.

Authors:  T Kraus; A Mehrabi; E Klar; D Mathias; J Arnold; G Otto; C Herfarth
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Increased endothelin level after cyclosporine therapy.

Authors:  G Deray; A Carayon; P Le Hoang
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

3.  A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients.

Authors:  R B Colvin; F I Preffer; T C Fuller; M C Brown; S H Ip; P C Kung; A B Cosimi
Journal:  Transplantation       Date:  1989-11       Impact factor: 4.939

4.  Intercellular adhesion molecule 1 on liver allografts during rejection.

Authors:  D H Adams; S G Hubscher; J Shaw; R Rothlein; J M Neuberger
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

5.  Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells.

Authors:  M Yoshizumi; H Kurihara; T Morita; T Yamashita; Y Oh-hashi; T Sugiyama; F Takaku; M Yanagisawa; T Masaki; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

6.  Monitoring of plasma endothelin in relation to Doppler signal in human liver transplantation.

Authors:  T Rudy; T Hartwig; E Fritschka; J Erhard; F W Eigler
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

7.  Tissue distribution and half-life of 125I-endothelin in the rat: importance of pulmonary clearance.

Authors:  M L Sirviö; K Metsärinne; O Saijonmaa; F Fyhrquist
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

8.  A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.

Authors:  T J Schroeder; T Helling; R M McKenna; D Rush; J R Jeffrey; B Brewer; L A Martin; D Traylor; R A Fisher; M R First
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

9.  The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.

Authors:  W C Sessa; S Kaw; M Hecker; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1991-01-31       Impact factor: 3.575

10.  Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.

Authors:  H Ehrenreich; R W Anderson; C H Fox; P Rieckmann; G S Hoffman; W D Travis; J E Coligan; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.